top of page

Understanding How Ketamine Brings About Rapid Improvement in OCD

About the study

NCT Trial Number

NCT02624596

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Stanford University|University of Connecticut

noun_date_3237048.png

Trial Start Date

Jun-16

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

OCD

noun_square_138133.png

Accepts healthy volunteers?

Yes

This study explores the mechanisms underlying the treatment outcomes from administering ketamine to treat OCD.

Eyes Graffiti

Locations

United States, California
Stanford University
Stanford, California, United States, 94305

Contact: Elizabeth McCarthy
650-723-4095
ocdresearch@stanford.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page